BlackRock Institutional Trust’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $32.7M | Buy |
1,026,199
+146,247
| +17% | +$4.66M | ﹤0.01% | 1606 |
|
|
2016
Q3 | $31.9M | Buy |
879,952
+73,601
| +9% | +$2.67M | 0.01% | 1575 |
|
|
2016
Q2 | $18.3M | Buy |
806,351
+82,063
| +11% | +$1.86M | ﹤0.01% | 1900 |
|
|
2016
Q1 | $13.6M | Buy |
724,288
+40,431
| +6% | +$760K | ﹤0.01% | 2061 |
|
|
2015
Q4 | $11.2M | Buy |
683,857
+27,558
| +4% | +$452K | ﹤0.01% | 2246 |
|
|
2015
Q3 | $7.21M | Sell |
656,299
-68,448
| -9% | -$752K | ﹤0.01% | 2499 |
|
|
2015
Q2 | $9.44M | Sell |
724,747
-12,320
| -2% | -$160K | ﹤0.01% | 2443 |
|
|
2015
Q1 | $12.8M | Buy |
737,067
+9,541
| +1% | +$166K | ﹤0.01% | 2229 |
|
|
2014
Q4 | $10.9M | Buy |
727,526
+17,770
| +3% | +$265K | ﹤0.01% | 2312 |
|
|
2014
Q3 | $16.4M | Buy |
709,756
+54,472
| +8% | +$1.26M | ﹤0.01% | 2004 |
|
|
2014
Q2 | $20.9M | Buy |
+655,284
| New | +$20.9M | ﹤0.01% | 1930 |
|